We found that TGF-β1/SMAD2/3 signaling mediates the stimulatory effect of hyperglycemia on DDR2 that in turn enhances collagen type 1 expression via ERK1/2 MAPK activation (Figs 2–4). The gene discussed is DDR2; the disease is Hyperglycemia.